Andersons pediatric cardiology 1678
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.28 KB, 3 trang )
obstructivecardiomyopathy:implicationsfor
concomitantvalveprocedures.JAmColl
Cardiol.2016;68(14):1497–1504.
241.YuEH,OmranAS,WigleED,etal.Mitral
regurgitationinhypertrophicobstructive
cardiomyopathy:relationshiptoobstructionand
reliefwithmyectomy.JAmCollCardiol.
2000;36(7):2219–2225.
242.KhairyP,VanHareGF,BalajiS,etal.
PACES/HRSexpertconsensusstatementonthe
recognitionandmanagementofarrhythmiasin
adultcongenitalheartdisease:developedin
partnershipbetweenthepediatricandcongenital
electrophysiologysociety(PACES)andtheheart
rhythmsociety(HRS).Endorsedbythe
governingbodiesofPACES,HRS,theAmerican
collegeofcardiology(ACC),theAmericanheart
association(AHA),theEuropeanheartrhythm
association(EHRA),theCanadianheartrhythm
society(CHRS),andtheinternationalsocietyfor
adultcongenitalheartdisease(ISACHD).Heart
Rhythm.2014;11(10):e102–e165.
243.KwonDH,SetserRM,PopovicZB,etal.
Associationofmyocardialfibrosis,
electrocardiographyandventricular
tachyarrhythmiainhypertrophic
cardiomyopathy:adelayedcontrastenhanced
MRIstudy.IntJCardiovascImaging.
2008;24(6):617–625.
244.KwonDH,SmediraNG,RodriguezER,etal.
Cardiacmagneticresonancedetectionof
myocardialscarringinhypertrophic
cardiomyopathy:correlationwithhistopathology
andprevalenceofventriculartachycardia.JAm
CollCardiol.2009;54(3):242–249.
245.LeonardiS,RaineriC,DeFerrariGM,etal.
Usefulnessofcardiacmagneticresonancein
assessingtheriskofventriculararrhythmiasand
suddendeathinpatientswithhypertrophic
cardiomyopathy.EurHeartJ.
2009;30(16):2003–2010.
246.FluechterS,KuschykJ,WolpertC,etal.Extent
oflategadoliniumenhancementdetectedby
cardiovascularmagneticresonancecorrelates
withtheinducibilityofventricular
tachyarrhythmiainhypertrophic
cardiomyopathy.JCardiovascMagnReson.
2010;12:30.
247.FrenneauxMP,PorterA,CaforioAL,etal.
Determinantsofexercisecapacityin
hypertrophiccardiomyopathy.JAmColl
Cardiol.1989;13(7):1521–1526.
248.FinocchiaroG,HaddadF,KnowlesJW,etal.
Cardiopulmonaryresponsesandprognosisin
hypertrophiccardiomyopathy:apotentialrole
forcomprehensivenoninvasivehemodynamic
assessment.JACCHeartFail.2015;3(5):408–
418.
249.CoatsCJ,RantellK,BartnikA,etal.
Cardiopulmonaryexercisetestingandprognosis
inhypertrophiccardiomyopathy.CircHeart
Fail.2015;8(6):1022–1031.
250.SadoulN,PrasadK,ElliottPM,etal.
Prospectiveprognosticassessmentofblood
pressureresponseduringexerciseinpatients
withhypertrophiccardiomyopathy.Circulation.
1997;96(9):2987–2991.
251.OlivottoI,MaronBJ,MontereggiA,etal.
Prognosticvalueofsystemicbloodpressure
responseduringexerciseinacommunity-based
patientpopulationwithhypertrophic
cardiomyopathy.JAmCollCardiol.
1999;33(7):2044–2051.
252.Ostman-SmithI,WettrellG,RiesenfeldT.A
cohortstudyofchildhoodhypertrophic
cardiomyopathy:improvedsurvivalfollowing
high-dosebeta-adrenoceptorantagonist
treatment.JAmCollCardiol.1999;34(6):1813–
1822.
253.RobertsonCE,MillerHC.Extremetachycardia
complicatingtheuseofdisopyramideinatrial
